Strategy for the prediction and selection of drug substance salt forms

Pharmaceutical Technology

Volumn 31, Issue 10, 2007, Pages 78-88

  Brittain, Harry G ^a,b  

^a Center for Pharmaceutical Physics   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACIDS; IONIZATION;

COUNTER-IONS; DRUG SUBSTANCES; FORMATION CONSTANTS; IONIC EQUILIBRIUM; IONIZATION CONSTANTS; TRIAL-AND-ERROR METHODS;

FORMING;

ACID; BASE; DRUG;

DRUG FORMULATION; DRUG STABILITY; HIGH THROUGHPUT SCREENING; IONIZATION; REVIEW;

EID: 53649083004     PISSN: 15432521     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (16)

1. S.M. Berge, L.D. Bighley, and D.C. Monkhouse, "Pharmaceutical Salts," J. Pharm. Sci. 66 (1), 1-19 (1977).
2. B.D. Anderson and K.P. Flora, "Preparation of Water-Soluble Compounds Through Salt Formation," in The Practice of Medicinal Chemistry, C.G. Wermuth, Ed. (Academic Press, New York, NY, 1996), pp. 739-754.
3. P.H. Stahl and C.G. Wermuth, Handbook of Pharmaceutical Salts (Wiley-VCH, Weinheim, Germany, 2002.)
4. L.D. Bighley, S.M. Berge, and D.C. Monkhouse, "Salt Forms of Drugs and Absorption," in Encyclopedia of Pharmaceutical Technology, J. Swarbrick and J.C. Boylan JC, Eds. (Marcel Dekker, New York, NY, 1995), pp. 453-499.
5. E.C. Ware and D.R. Lu, "An Automated Approach to Salt Selection for New Unique Trazodone Salts," Pharm. Res. 21 (1), 177-184 (2004).
6. D.A. Haynes, W. Jones, and W.D.S. Motherwell, "Occurrence of Pharmaceutically Acceptable Anions and Cations in the Cambridge Structural Database," J. Pharm. Sci. 94 (10), 2111-2120 (2005).
7. P.L. Gould, "Salt Selection for Basic Drugs," Int. J. Pharm. 33 (1-2), 201-217 (1986).
8. K.R. Morris et al., "An Integrated Approach to the Selection of Optimal Salt Form for a New Drug Candidate," Int. J. Pharm. 105 (2), 209-217 (1994).
9. W-Q. Tong and G. Whitesell, "In Situ Salt Screening - A Useful Technique for Discovery Support and Preformulation Studies," Pharm. Dev. Tech. 3 (2), 215-223 (1998).
10. M. Sacchetti, "General Equations for In Situ Salt Screening of Multibasic Drugs in Multiprotic Acids," Pharm. Dev. Tech. 5 (4), 579-582 (2000).
11. R.J.Bastin, M.J. Bowker, and B.J. Slater, "Salt Selection and Optimization Procedures for Pharmaceutical New Chemical Entities," Org. Proc. Res. Dev. 4 (5), 427-435 (2000).
12. A.T.M. Serajuddin and M. Pudipeddi, "Salt-Selection Strategies," in Handbook of Pharmaceutical Salts, P.H. Stahl and C.G. Wermuth, Eds. (Wiley-VCH, Weinheim, Germany, 2002), pp. 135-160.
13. M.J. Bowker, "A Procedure for Salt Selection and Optimization," in Handbook of Pharmaceutical Salts, P.H. Stahl and C.G. Wermuth, Eds. (Wiley-VCH, Weinheim, Germany, 2002), pp. 161-189.
14. R.B. Hammond et al., "Grid-Based Molecular Modeling for Pharmaceutical Salt Screening: Case Example of 3,4,5,7,8,9-hexahydro-2H- pyrimido-(1,2-a)-primidinium acetate," J. Pharm. Sci. 95 (11), 2361-2372 (2006).
15. Lange's Handbook of Chemistry, J.A. Dean, Ed. (McGraw-Hill, New York, NY, 12th edition, 1979), pp. 5-7.
16. J.D Higgins et al., "Ibuprofen," in Analytical Profiles of Drug Substances and Excipients, vol. 27, H.G. Brittain, Ed. (Academic Press, San Diego, CA, 2001), pp. 265-300.